This is a preview of subscription content, log in via an institution to check access.
References
Gholitabar M, McGuire H, Rennie J, Manning D, Lai R. Clofibrate in combination with phototherapy for unconjugated neonatal hyperbilirubinaemia. Cochrane Database Syst Rev. 2012;12:CD009017.
Kumar P, Adhisivam B, Bhat BV. Clofibrate as an adjunct to phototherapy for unconjugated hyperbilirubinemia in term neonates. Indian J Pediatr. 2017; doi:10.1007/s12098-017-2360-y.
Maisels MJ, Bhutani VK, Bogen D, Newman TB, Stark AR, Watchko JF. Hyperbilirubinemia in the newborn infant > or =35 weeks’ gestation: an update with clarifications. Pediatrics. 2009;124:1193–8.
Rennie J, Burman-Roy S, Murphy MS. Neonatal jaundice: summary of NICE guidance. BMJ. 2010;340:c2409.
Nesfield SR, Clarke CJ, Hoivik DJ, et al. Evaluation of the carcinogenic potential of clofibrate in the rasH2 mouse. Int J Toxicol. 2005;24:301–11.
Torrey CE, Wall HG, Campbell JA, et al. Evaluation of the carcinogenic potential of clofibrate in the FVB/tg.AC mouse after dermal application--part II. Int J Toxicol. 2005;24:327–39.
WHO cooperative trial on primary prevention of ischaemic heart disease with clofibrate to lower serum cholesterol: final mortality follow-up. Report of the Committee of Principal Investigators. Lancet. 1984;2:600–4.
Orange book: approved drug products with therapeutic equivalence evaluations [Internet]. Available at: https://www.accessdata.fda.gov/scripts/cder/ob/search_product.cfm. Accessed on 19 July 2017.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
None.
Source of Funding
None.
Rights and permissions
About this article
Cite this article
Chawla, D. Clofibrate in Neonatal Hyperbilirubinemia. Indian J Pediatr 84, 735–736 (2017). https://doi.org/10.1007/s12098-017-2438-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12098-017-2438-6